pfizer recalls pain drug acquired in king deal
just weeks after completing its $3.6 billion purchase of king pharmaceuticals, pfizer inc has recalled an opioid painkiller obtained in the deal and said it could remain unavailable for many months because of formulation problems.
http://feeds.reuters.com/~r/reuters/healthnews/~3/wljz-k_-fu0/us-pfizer-recall-idustre72fa3q20110316
18084
17 Mar 2011 00:58:17
reuters
health